Silence Therapeutics Stock Forecast

SLN's stock price has decreased by -84.85% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

The 5 analysts with 12-month price forecasts for Silence Therapeutics stock have an average target of 40.8, with a low estimate of 4.00 and a high estimate of 75. The average target predicts an increase of 1,108.89% from the current stock price of 3.38.

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$4.00	$40.8	$45	$75
Change	+18.52%	+1108.9%	+1233.3%	+2122.2%

* Price targets were last updated on Mar 7, 2025.

Analyst Ratings

The average analyst rating for Silence Therapeutics stock from 5 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Nov '24	Dec '24	Jan '25	Feb '25	Mar '25	Apr '25
Strong Buy	2	2	2	2	2	2
Buy	2	2	2	1	2	2
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	1	1	1
Total	4	4	4	4	5	5

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Patrick Trucchio HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $75	Strong Buy	Reiterates	$75	+2,122.22%	Mar 7, 2025
Michael Ulz Morgan Stanley	Morgan Stanley	Buy Maintains $49 → $45	Buy	Maintains	$49 → $45	+1,233.33%	Mar 5, 2025
Kostas Biliouris BMO Capital	BMO Capital	Buy Maintains $67 → $25	Buy	Maintains	$67 → $25	+640.74%	Mar 4, 2025
Richard Law Goldman Sachs	Goldman Sachs	Strong Sell Maintains $6 → $4	Strong Sell	Maintains	$6 → $4	+18.52%	Mar 4, 2025
Richard Law Goldman Sachs	Goldman Sachs	Strong Sell Initiates $6	Strong Sell	Initiates	$6	+77.78%	Feb 11, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

32.34M

from 43.26M

-25.23%

from 43.26M

Revenue Next Year

n/a

from 32.34M

EPS This Year

n/a

from -0.98

EPS Next Year

n/a

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025
Revenue	5.48M	12.42M	21.66M	31.64M	43.26M	32.34M
Revenue Growth	2,145.49%	126.59%	74.43%	46.12%	36.71%	-25.23%
EPS	-1.19	-1.33	-1.56	-1.46	-0.98	-
EPS Growth	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	6

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025
High	74.5M
Avg	32.3M
Low	10.3M

Revenue Growth

Revenue Growth	2025
High	72.2%
Avg	-25.2%
Low	-76.3%

EPS Forecast

EPS
High
Avg
Low

EPS Growth

EPS Growth
High
Avg
Low

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.